- Home
- EDIT vs PKBK Comparison
EDIT vs PKBK Comparison
Compare EDIT & PKBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EDIT | PKBK |
|---|---|---|
| Founded | 2013 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 432.8M | 353.1M |
| IPO Year | 2016 | 2005 |
Fundamental Metrics
Financial Performance| Metric | EDIT | PKBK |
|---|---|---|
| Price | $3.63 | $33.06 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $5.30 | N/A |
| AVG Volume (30 Days) | ★ 2.6M | 61.5K |
| Earning Date | 05-11-2026 | 04-17-2026 |
| Dividend Yield | N/A | ★ 2.40% |
| EPS Growth | 37.50 | ★ 39.21 |
| EPS | N/A | ★ 0.99 |
| Revenue | ★ $31,937,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $33.26 |
| Revenue Growth | ★ 132.64 | N/A |
| 52 Week Low | $1.66 | $19.71 |
| 52 Week High | $4.54 | $34.00 |
Technical Indicators
Market Signals| Indicator | EDIT | PKBK |
|---|---|---|
| Relative Strength Index (RSI) | 70.63 | 62.63 |
| Support Level | $2.26 | $29.95 |
| Resistance Level | $3.65 | N/A |
| Average True Range (ATR) | 0.24 | 0.71 |
| MACD | 0.11 | 0.10 |
| Stochastic Oscillator | 96.99 | 70.57 |
Price Performance
Historical ComparisonAbout EDIT Editas Medicine Inc.
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary gene editing platform based on CRISPR technology and continues to expand its capabilities. CRISPR uses a protein-RNA complex composed of an enzyme, including either Cas9 (CRISPR-associated protein 9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1). The company has a single operating segment, which is the business of developing and commercializing gene editing technology.
About PKBK Parke Bancorp Inc.
Parke Bancorp Inc operates as a commercial bank providing personal and financial services to individuals and small to mid-sized businesses in various states of the USA. The bank offers services such as loan products, deposit services, and other financial products through its retail branches and other channels to its customers. Its lending businesses are commercial real estate lending, residential real estate lending, and construction lending, among others. The company operates one reportable segment of business, community banking.